Population
Cancer patients or candidates treated with potentially cardiotoxic cancer therapy in Italy
Design
Guideline
Authors
Loading...
Shared CVD-cancer risks and treatment effects heighten complications in elderly survivors; leaves open optimal integrated risk assessment strategies.
This consensus document establishes multidisciplinary clinical pathways for the cardio-oncological management of cancer patients to minimize the risk of cardiotoxicity.
Tarantini et al. (2017) conducted a review in Cardiovascular complications in cancer patients. Cardio-oncology clinical and management pathways was evaluated. This consensus document provides practical recommendations on how to assess, monitor, treat, and supervise patients receiving potentially cardiotoxic cancer therapy to protect the heart.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: